GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » Interest Expense

Medical Developments International (ASX:MVP) Interest Expense : A$-0.09 Mil (TTM As of Jun. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medical Developments International Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medical Developments International's interest expense for the six months ended in Jun. 2024 was A$ -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.09 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medical Developments International's Operating Income for the six months ended in Jun. 2024 was A$ -3.87 Mil. Medical Developments International's Interest Expense for the six months ended in Jun. 2024 was A$ -0.04 Mil. Medical Developments International did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medical Developments International Interest Expense Historical Data

The historical data trend for Medical Developments International's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Developments International Interest Expense Chart

Medical Developments International Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 -0.01 -0.10 -0.10 -0.09

Medical Developments International Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.05 -0.05 -0.04 -0.04

Medical Developments International Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Developments International  (ASX:MVP) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medical Developments International's Interest Expense for the six months ended in Jun. 2024 was A$-0.04 Mil. Its Operating Income for the six months ended in Jun. 2024 was A$-3.87 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was A$1.92 Mil.

Medical Developments International's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Medical Developments International did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Medical Developments International Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » Interest Expense
Comparable Companies
ASX:IDT ASX:NXS ASX:LGP ASX:VIT ASX:SNT ASX:CAN ASX:ECS ASX:EOF ASX:PER ASX:AGH ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
N/A
Address
4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Website
https://www.medicaldev.com
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Medical Developments International Headlines

From GuruFocus

Roundhill Announces Two Fund Closures

By PRNewswire PRNewswire • 03-18-2022

Medical Developments International Stock Appears To Be Possible Value Trap

By GF Value • 01-01-1970